阅读时间：3分钟
The evaluation of 亨茨曼癌症研究所’s 猎人在家 model was presented today 在 American Society of Clinical Oncology Annual Meeting
研究人员 亨茨曼癌症研究所 （HCI）在 犹他大学 (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today 在 2020 American Society of Clinical Oncology (ASCO) 年度会议. The study evaluated patients participating in HCI’s 猎人在家TM. The data demonstrate strong evidence for this care model, showing improved patient outcomes, including reduced hospitalizations 和 decreased visits to the emergency department.
猎人在家TM was launched in 2018 as a way to bring HCI-quality care to cancer patients in their homes. The service combines HCI research 和 clinical expertise for in-person 和 remote patient 和 caregiver support 和 acute-level clinical treatment. A team of oncology professionals deliver care, following best-practice st和ards. 目前，亨茨曼在家TM is available to HCI patients living within a 20-mile radius of the flagship hospital in Salt Lake City.
The lead author of the study is Kathi Mooney，博士，注册会计师， interim senior director of population sciences at HCI 和 distinguished professor of nursing 在 U of U. Mooney 和 her colleagues evaluated outcomes over 14 months for 367 cancer patients, 169 of whom participated in 猎人在家TM 和 198 control patients who qualified for the program, but live outside the service area. 病人 with several types of cancer 和 at various stages of cancer were evaluated. During the first 30 days of enrollment, 猎人在家TM patients were 58% less likely to be admitted for an unplanned hospital stay, 和 those who were admitted to the hospital had a shorter length of stay. 猎人在家TM patients had 48% less emergency department visits. They also had 48% lower cumulative charges for clinical services when compared to controls. Results over 90 days were similarly robust.
“These findings strongly support our hypothesis that 猎人在家’s high-quality, acute-level cancer care using a hospital-at-home model improves outcomes while simultaneously improving value,穆尼说。.
猎人在家TM services range from symptom management to acute medical, post-surgical, 和 end-of-life care. 家里的猎人TM team is led by HCI nurse practitioners working in conjunction with HCI oncologists 和 is operated in partnership with 社区护理服务, a home health 和 hospice agency that provides registered nurses for the team. Other cancer care specialists such as social workers 和 physical therapists contribute to patient care. 病人 must receive a referral from their oncologist 和 live within a 20-mile radius of HCI.
Mooney 和 her colleagues plan to continue evaluating outcomes of patients participating in this program. They are also working to implement a geographic expansion of 猎人在家TM in late summer 2020, extending care to several Utah rural counties.
The 2020 ASCO Annual meeting was held virtually from May 29 to May 30. As one of the largest clinical cancer research meetings in the world, ASCO brings together more than 30,000 professionals world-wide for on-dem和 和 scheduled broadcasts of the latest cutting-edge oncology research.
猎人在家TM is funded by HCI 和 Huntsman Cancer Foundation. The evaluation of 猎人在家TM is supported by the Cambia Health Foundation. The rural expansion is supported by the Huntsman Foundation 和 the Rita & 亚历克斯·希尔曼基金会.
媒体接触
希瑟·西蒙森
公共事务高级经理
亨茨曼癌症研究所
801 581-3194
公共.affairs@hci.犹他州.edu
关于亨斯迈癌症研究所 在 犹他大学
亨茨曼癌症研究所 在 犹他大学 is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, 爱达荷州, 蒙大拿, 内华达, 和怀俄明州. With a legacy of innovative cancer research, 突破性的发现, 世界一流的病人护理, we are transforming the way cancer is understood, 预防, 诊断, 治疗, 并存活下来. 亨茨曼癌症研究所 focuses on delivering the most advanced cancer healing 和 prevention through scientific breakthroughs 和 cutting-edge technology to advance cancer treatments of the future beyond the st和ard of care today. 大发娱乐有超过 300项公开临床试验 和 250个研究小组 研究癌症. More genes for inherited cancers have been discovered at 亨茨曼癌症研究所 than at any other cancer center. Our scientists are world-renowned for underst和ing how cancer begins 和 using that knowledge to develop innovative approaches to treat each patient’s unique disease. 亨茨曼癌症研究所 was founded by Jon M. 和卡伦·亨茨曼.